Replies to post #216152 on Biotech Values

[DewDiligence]

ADXS reports FY4Q17 results:

https://www.businesswire.com/news/home/20171220006059/en

In 2017 the Company completed an in-depth review of all spend and has eliminated programs that were not supportive of its strategic goals. Due to this increased discipline, the Company has returned to the historical quarterly burn rate of approximately $20 million in the fourth quarter of 2017, excluding partnership reimbursement and other cash receivables.

ADXS’ pro forma cash at 10/31/17 (end of FY2017) is $75.4M. This figure consists of: $70.9M of cash on the 4Q17 balance sheet; and $4.5M of cash due from New Jersey as proceeds from the monetization of NOLs.

CC tomorrow at 10am ET.